Efficacy of erdafitinib in adults with advanced solid tumors and non-prespecified fibroblast growth factor receptor mutations in the phase 2 RAGNAR trial: Exploratory cohort Meeting Abstract
| Authors: | Lugowska, I. A.; Schuler, M. H.; Loriot, Y.; Carranza, O.; Iyer, G.; Doi, T.; Qin, S.; Tabernero, J.; Reardon, D. A.; Massard, C.; Arnold, D.; Gutierrez, M.; Winter, H.; Sweiti, H.; Xia, K.; Najmi, S.; Hammond, C.; Thomas, S.; Triantos, S.; Pant, S. |
| Abstract Title: | Efficacy of erdafitinib in adults with advanced solid tumors and non-prespecified fibroblast growth factor receptor mutations in the phase 2 RAGNAR trial: Exploratory cohort |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557400721 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.3119 |
| Notes: | Meeting Abstract: 3119 -- Source: Wos |
